Q32 Bio Inc.(QTTB:US)
Market Cap$110.01M
Key Metrics
Price$7.52
Revenue (TTM)$53.74M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)$33.24M
EBITDA (TTM)$34.29M
Op. Margin (TTM)39.84%
Dividend Yield-
Holders Yield-
Cash on hand$50.75M
Total Assets$63.68M
Net Assets$46.31M
Total Debt$13.65M
Key Metrics
Price$7.52
Revenue (TTM)$53.74M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)$33.24M
EBITDA (TTM)$34.29M
Op. Margin (TTM)39.84%
Dividend Yield-
Holders Yield-
Cash on hand$50.75M
Total Assets$63.68M
Net Assets$46.31M
Total Debt$13.65M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $53.74M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.86M | $3.21M | $2.95M | $3.78M |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $7.72M | $7.86M | $7.58M | $9.17M | $12.23M | $14.53M | $18.81M | $17.92M | $14.84M | $9.66M | $10.48M | $10.32M | $11.69M | |
| Research and Development | $3.22M | $3.32M | $3.56M | $5.16M | $7.12M | $10.55M | $14.35M | $13.41M | $9.84M | $7.46M | $8.02M | $7.91M | $9.19M |
| Selling, General, and Administrative | $4.5M | $4.54M | $4.02M | $4.01M | $5.1M | $3.98M | $4.47M | $4.51M | $5M | $2.19M | $2.46M | $2.41M | $2.5M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$7.72M | $45.88M | -$7.58M | -$9.17M | -$12.23M | -$14.53M | -$18.81M | -$17.92M | -$14.84M | -$7.8M | -$7.28M | -$7.37M | -$7.91M |
| $113K | $11.85M | $188K | -$300K | $1.3M | -$2.44M | $1.22M | $941K | $16.05M | -$6.17M | $1.47M | $535K | -$1.76M | |
| Non-Operating Interest Income | - | $400K | $500K | $600K | $700K | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | - | $200K | $300K | $300K | $300K | - | - | - | - | - | - | - | - |
| Other Income/Expense | $113K | $11.65M | -$12K | -$600K | $900K | -$2.44M | $1.22M | $941K | $16.05M | -$6.17M | $1.47M | $535K | -$1.76M |
Income Before Tax | -$7.61M | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.17M | -$17.6M | -$16.98M | $1.21M | -$13.97M | -$5.81M | -$6.84M | -$9.67M |
Income Tax | - | - | - | $0 | $0 | $21K | $0 | - | - | $65K | - | - | $17K |
Net Income | -$7.61M | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.19M | -$17.6M | -$16.98M | $1.03M | -$14.03M | -$5.81M | -$6.84M | -$9.69M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$7.61M | $57.73M | -$7.39M | -$9.49M | -$11.03M | -$14.19M | -$17.6M | -$16.98M | $1.03M | -$14.03M | -$5.81M | -$6.84M | -$9.69M |
Shares Outstanding (Basic) | 14.1M | - | 12.24M | 12.2M | 12.2M | - | 12.08M | 11.96M | 11.93M | 11.93M | 11.93M | 11.93M | - |
Shares Outstanding (Diluted) | 14.1M | - | 12.24M | 12.2M | 12.2M | - | 12.08M | 11.96M | 11.93M | 11.93M | 11.93M | 11.93M | - |
EPS (Basic) | -$0.54 | - | -$0.60 | -$0.78 | -$0.90 | - | -$1.46 | -$1.42 | $0.086 | -$1.18 | -$0.49 | -$0.57 | - |
EPS (Diluted) | -$0.54 | - | -$0.60 | -$0.78 | -$0.90 | - | -$1.46 | -$1.42 | $0.086 | -$1.18 | -$0.49 | -$0.57 | - |
EBIT | -$7.72M | $57.93M | -$7.09M | -$9.19M | -$10.73M | $6.59M | -$18.81M | -$17.92M | -$14.84M | -$7.8M | -$7.28M | -$7.37M | -$7.91M |
EBITDA | -$7.63M | $58.02M | -$7M | -$9.1M | -$10.51M | $7.41M | -$18.69M | -$17.8M | -$30.61M | -$1.42M | -$8.45M | -$7.2M | -$6.38M |